- No posts yet.
- Proteome expansion and subsequent reproducibility crisis define a year of structural recalibration in metaproteomics. 365-day briefing • 2025-07-28 - 2026-07-27
- Metaproteomics standardization advances; microbiome studies link dysbiosis to disease risk. 7-day briefing • 2026-07-21 - 2026-07-27
- Metabolite glues and diet-driven tumorigenesis highlight new mechanisms in microbiome and metabolism research 7-day briefing • 2026-07-15 - 2026-07-21
- Community benchmarking study finds only 3.5% of microprotein detections replicate, highlighting reproducibility crisis. 7-day briefing • 2026-07-01 - 2026-07-07
- Spatial human proteome map across tissues and cancers published; microbiome benchmarking shows reproducibility gaps 7-day briefing • 2026-06-17 - 2026-06-23
- Multi-species transcriptomic clocks and metabolic axes dominate a week of high-impact omics studies. 7-day briefing • 2026-05-27 - 2026-06-02
- Proteome expansion via ncORF translation emerges as sustained theme across limited window 30-day briefing • 2026-04-27 - 2026-05-26
- Proteome expansion via non-canonical ORFs emerges as quarterly defining shift, with ~1,700 new microproteins and peptideins 90-day briefing • 2026-02-26 - 2026-05-26
- Proteome expansion via non-canonical ORFs solidifies as the year's defining structural shift, with ~1,700 new microproteins and peptideins identified. 365-day briefing • 2025-05-27 - 2026-05-26
- Large-scale proteomics identifies ~1,700 new microproteins from non-canonical ORFs, expanding the human proteome 7-day briefing • 2026-05-20 - 2026-05-26
- NeoGenomics Launches RaDaR ST, Expanding MRD Testing Across Multiple Solid Tumors businesswire.com | 152d ago
- NeoGenomics Launches PanTracer LBx to Expand Access to Comprehensive Genomic Profiling via Liquid Biopsy businesswire.com | 362d ago
- NeoGenomics Launches PanTracer Tissue and PanTracer Tissue HRD for Cancer Care businesswire.com | 392d ago
Showing page 1 of 2
(21 total results)
← Prev
Next →